These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7922700)

  • 1. A stopping rule for standard chemotherapy for metastatic breast cancer: lessons from a survey of Maryland medical oncologists.
    Benner SE; Fetting JH; Brenner MH
    Cancer Invest; 1994; 12(5):451-5. PubMed ID: 7922700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Treatment Patterns Among Postmenopausal Women with HR+/HER2- Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study.
    Goldschmidt D; Dalal AA; Romdhani H; Kelkar S; Guerin A; Gauthier G; Wu EQ; Niravath P; Small T
    Adv Ther; 2018 Apr; 35(4):482-493. PubMed ID: 29582246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J; Jönsson PE; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):253-81. PubMed ID: 11441936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
    Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy after second-line chemotherapy for patients with advanced or metastatic breast cancer].
    Ogasawara Y; Doihara H; Takahashi M; Kawasaki K; Taira N
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1713-6. PubMed ID: 18931574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India.
    Parikh PM; Gupta S; Parikh B; Smruti BK; Issrani J; Topiwala S; Goswami C; Bhattacharya GS; Sen T; Sekhon JS; Malhotra H; Nag S; Chacko RT; Govind KB; Raja T; Vaid AK; Doval DC; Gupta S; Das PK
    Indian J Cancer; 2011; 48(2):158-64. PubMed ID: 21768659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Pemetrexed-based Chemotherapy for Patients with Locally Advanced or Metastatic Cancers.
    Qian T; Huang XE
    Asian Pac J Cancer Prev; 2015; 16(11):4791-5. PubMed ID: 26107242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.
    Dufresne A; Pivot X; Tournigand C; Facchini T; Altweegg T; Chaigneau L; De Gramont A
    Breast Cancer Res Treat; 2008 Jan; 107(2):275-9. PubMed ID: 17380382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.
    Davda R; Hughes S; Jones R; Crabb SJ; Troup J; Payne H
    Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):376-85. PubMed ID: 26874654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System.
    Rashid N; Koh HA; Baca HC; Li Z; Malecha S; Abidoye O; Masaquel A
    J Manag Care Spec Pharm; 2015 Oct; 21(10):863-71. PubMed ID: 26402387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.
    Donato BM; Burns L; Willey V; Cohenuram M; Oliveria S; Yood MU
    Clin Ther; 2010 Mar; 32(3):546-54. PubMed ID: 20399992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer.
    Seal BS; Anderson S; Shermock KM
    J Manag Care Spec Pharm; 2016 Mar; 22(3):227-35. PubMed ID: 27003552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts' experiences in the Netherlands.
    Spronk PER; de Ligt KM; van Bommel ACM; Siesling S; Smorenburg CH; Vrancken Peeters MTFD;
    Patient Educ Couns; 2018 Dec; 101(12):2111-2115. PubMed ID: 30054106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
    Krop IE; Kim SB; Martin AG; LoRusso PM; Ferrero JM; Badovinac-Crnjevic T; Hoersch S; Smitt M; Wildiers H
    Lancet Oncol; 2017 Jun; 18(6):743-754. PubMed ID: 28526538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and duration in post-menopausal women with HR+/HER2- metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004-2010).
    Macalalad AR; Hao Y; Lin PL; Signorovitch JE; Wu EQ; Ohashi E; Zhou Z; Kelley C
    Curr Med Res Opin; 2015 Feb; 31(2):263-73. PubMed ID: 25350226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.
    Seah DS; Scott S; Guo H; Najita J; Lederman R; Frank E; Sohl J; Stadler Z; Silverman S; Peppercorn J; Winer E; Come S; Lin NU
    Oncologist; 2015 Sep; 20(9):992-1000. PubMed ID: 26240134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of aging on the utilization of chemotherapy for metastatic breast cancer: a population-based study.
    Fetting JH; Comstock GW; Eby S; Huelskamp AM; Sullivan SA; Zahurak M; Gerber J; Kass FH; Smith R
    Cancer Invest; 1997; 15(3):199-203. PubMed ID: 9171852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.